"As they raced to develop vaccines, researchers in the biotech industry have become heroes in the battle against Covid-19. But carving out a career in the biotech industry can take many years of struggle.”

Two major skin microbiome companies have received investments this week: the Belgian company S-Biomedic, which is developing a probiotic acne treatment, and the UK biotech SkinBioTherapeutics, which is targeting eczema.

An international team of scientists has used mixtures of different skin microbial components to temporarily modulate the composition of recipient skin bacteria for therapeutic or cosmetic purposes.